Stone Shi

Stone Shi is a highly experienced scientific professional with a focus on analytical and formulation development in the pharmaceutical industry. Currently serving as a Senior Principal Research Scientist at AbbVie since January 2025, Stone Shi previously held significant leadership roles at WuXi XDC as Senior Director of XDC CMC Management, and at ASKGENE PHARMA, INC. as Vice President of Analytical and Formulation Development. Stone Shi's past experiences include critical positions at Amgen, Pfizer, and GlaxoSmithKline, where expertise in mass spectrometry and protein characterization was developed. Stone Shi earned a Ph.D. in Analytical Chemistry from Florida State University and holds both MS and BS degrees in Organic Chemistry and Chemistry, respectively, from Tsinghua University.